James A. Hadley

4.9k total citations · 1 hit paper
53 papers, 2.1k citations indexed

About

James A. Hadley is a scholar working on Otorhinolaryngology, Immunology and Allergy and Surgery. According to data from OpenAlex, James A. Hadley has authored 53 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Otorhinolaryngology, 19 papers in Immunology and Allergy and 16 papers in Surgery. Recurrent topics in James A. Hadley's work include Sinusitis and nasal conditions (19 papers), Allergic Rhinitis and Sensitization (18 papers) and Asthma and respiratory diseases (13 papers). James A. Hadley is often cited by papers focused on Sinusitis and nasal conditions (19 papers), Allergic Rhinitis and Sensitization (18 papers) and Asthma and respiratory diseases (13 papers). James A. Hadley collaborates with scholars based in United States, United Kingdom and Germany. James A. Hadley's co-authors include J. David Osguthorpe, Michael S. Benninger, Bradley F. Marple, Berrylin J. Ferguson, Ivor A. Emanuel, Howard L. Levine, Michael R. Jacobs, David W. Kennedy, Jack B. Anon and James A. Stankiewicz and has published in prestigious journals such as Environmental Science & Technology, The Journal of Immunology and Spine.

In The Last Decade

James A. Hadley

49 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and Pathophysiology

2003 764 citations Michael S. Benninger, James A. Hadley et al. profile →

Peers

Countries citing papers authored by James A. Hadley

Since Specialization

Citations

This map shows the geographic impact of James A. Hadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Hadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Hadley more than expected).

Fields of papers citing papers by James A. Hadley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Hadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Hadley. The network helps show where James A. Hadley may publish in the future.

Co-authorship network of co-authors of James A. Hadley

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Hadley. A scholar is included among the top collaborators of James A. Hadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Hadley. James A. Hadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Competition: ContikiMAC with Differentiating Clear Channel Assessment 2016 ·(unknown), James A. Hadley, Utz Roedig	1
2	Skin prick/puncture testing in North America: a call for standards and consistency 2014 ·Allergy Asthma and Clinical Immunology ·(unknown), (unknown), James A. Hadley	32
3	The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: provider practices and beliefs about allergen immunotherapy 2014 ·International Forum of Allergy & Rhinology ·Bryan Leatherman, David P. Skoner, James A. Hadley, (unknown), Michael S. Blaiss, Mark S. Dykewicz, Timothy Craig, Nancy Smith, Felicia Allen‐Ramey	12
4	ACR Appropriateness Criteria Headache 2014 ·Journal of the American College of Radiology ·(unknown), Franz J. Wippold, Daniel F. Broderick, Ashley H. Aiken, Sepideh Amin‐Hanjani, Douglas Brown, Amanda S. Corey, Isabelle M. Germano, James A. Hadley, Bharathi Jagadeesan, (unknown), Tabassum A. Kennedy, Laszlo Mechtler, Nandini Patel, Gregory J. Zipfel	62
5	Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis 2014 ·The Journal of Allergy and Clinical Immunology In Practice ·William E. Berger, Shailen Shah, Phil Lieberman, James A. Hadley, David Price, Ullrich Munzel, Sanjay Bhatia	47
6	Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis 2013 ·International Archives of Allergy and Immunology ·Eli O. Meltzer, Paul H. Ratner, Claus Bachert, Warner Carr, William E. Berger, Giorgio Walter Canonica, James A. Hadley, Phil Lieberman, Frank C. Hampel, Joaquim Mullol, Ullrich Munzel, David Price, Glenis Scadding, J. Christian Virchow, U. Wahn, Ruth Murray, Jean Bousquet	84
7	Otoscopic Signs of Otitis Media 2011 ·The Pediatric Infectious Disease Journal ·Nader Shaikh, Alejandro Hoberman, Phillip H. Kaleida, Howard E. Rockette, Marcia Kurs‐Lasky, (unknown), Michael E. Pichichero, (unknown), Christopher J. Harrison, James A. Hadley, Richard H. Schwartz	36
8	Nasal Allergy Survey Assessing Limitations (NASL) 2010 Survey: Allergic Rhinitis Continues to Impact Patient Quality of Life 2011 ·Journal of Allergy and Clinical Immunology ·Gary N. Gross, Rohit Katial, James A. Hadley, Bradley F. Marple, (unknown), Stuart Stoloff	1
9	Moxifloxacin five‐day therapy versus placebo in acute bacterial rhinosinusitis 2010 ·The Laryngoscope ·James A. Hadley, Ralph Mösges, Martin Desrosiers, Daniel Haverstock, David van Veenhuyzen, (unknown)	22
10	Cephalosporin use in treatment of patients with penicillin allergies 2008 ·Journal of the American Pharmacists Association ·Daryl D. DePestel, Michael S. Benninger, Larry H. Danziger, Kerry L. LaPlante, (unknown), Allan T. Luskin, (unknown), James A. Hadley	76
11	Cutting Edge: Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Inhibits Memory B Lymphocytes via Effects on Lymphoid Germinal Centers and Follicular Dendritic Cell Networks 2008 ·The Journal of Immunology ·Jennifer H. Anolik, (unknown), Jennifer Barnard, Teresa Owen, Anthony Almudevar, E C Milner, (unknown), Paul O. Dutcher, James A. Hadley, Iñaki Sanz	113
12	The efficacy of cefdinir in acute bacterial rhinosinusitis 2006 ·Expert Opinion on Pharmacotherapy ·James A. Hadley	0
13	Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis 2006 ·Expert Review of Anti-infective Therapy ·James A. Hadley, Glenn Tillotson, Robert Tosiello, Roger Echols	7
14	Esophageal Coin With an Unusual Radiographic Appearance 2005 ·Pediatric Emergency Care ·Gregory P. Conners, James A. Hadley	11
15	Cost-effective pharmacotherapy for inhalant allergic rhinitis 2003 ·Otolaryngologic Clinics of North America ·James A. Hadley	5
16	The microbiology and management of acute and chronic rhinosinusitis 2001 ·Current Infectious Disease Reports ·James A. Hadley	9
17	The role of medical management in rhinosinusitis 2001 ·Current Opinion in Otolaryngology & Head & Neck Surgery ·James A. Hadley	1
18	RHINOSINUSITIS 1999 ·Medical Clinics of North America ·J. David Osguthorpe, James A. Hadley	47
19	OVERVIEW OF OTOLARYNGIC ALLERGY MANAGEMENT 1998 ·Otolaryngologic Clinics of North America ·James A. Hadley	7
20	A prospective randomized controlled trial comparing the use of merocel nasal tampons and BIPP in the control of acute epistaxis 1995 ·Clinical Otolaryngology ·Rogan Corbridge, B Djazaeri, (unknown), James A. Hadley	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact